While Canadians might be gearing up for the introduction of the edibles market, across the border, cannabidiols (CBD) have been the hottest trend as of late. CBD provides a lot of the medicinal benefits of marijuana without the actual high. CBD oil comes from the hemp plant, which is actually a cousin of the marijuana plant and not actually marijuana.
While hemp isnâ€™t legal everywhere, itâ€™s legal in enough areas of the United States for cannabis producers to see a huge market opportunity â€” especially as itâ€™s been proven to be completely safe for consumption. â€śIn humans, CBD exhibits no effects indicative of any abuse or dependence potential,â€ť according to the World Health Organization. â€śTo date, there is no evidence of public health related problems associated with the use of pure CBD.â€ť
In fact, there are some producers that have actually put the focus of its business almost solely on CBD products. Two such producers that investors might want to consider areÂ Charlotteâ€™s Web Holdings (TSX:CWEB) andÂ Cronos Group (TSX:CRON)(NASDAQ:CRON). But of these two producers, which is the better buy right now?
Charlotteâ€™s Webâ€™s strength comes from its position in the CBD industry. The company has been producing for a while now, even before the Farm Bill was passed in the United States. Since then, this has just opened up even more opportunities for the already strong company. The company is in the midst of boosting its production capacity, mainly because of the increase in its brick-and-mortar stores, of which it has 8,000 spread across the U.S.
Clearly, the company expects CBD to keep on a steady upward trajectory. Charlotteâ€™s Web recently increased its hemp acreage by 187% in 2019 compared to last year and has seen revenue growth of 45% year over year, even posting a profit of US$18.8 million. As marijuana is legalized across different states, those who might not necessarily want the recreational side effects of cannabis can still enjoy CBD. Thatâ€™s why Charlotteâ€™s Web is looking for every opportunity to expand, including through gummies and pet products!
The stock has had a bit of a slump but is still up almost 50% year to date.
Another CBD heavyweight is Cronos, though, unlike Charlotteâ€™s Web, this company is seeing massive growth mainly through acquisitions. The company received a ton of cash from partner Altria and has been slow to using it up. Most recently, the company acquired Redwood Holding Group, an owner of popular CBD brand Lord Jones, for US$300 million, giving it a position in the U.S. However, the company believes itâ€™s still as long as a year away from being set up in the U.S. CBD market.
Meanwhile, Cronos is striving ahead, especially through its earnings. The company recently announced an increase of 42% in its kilograms sold for the second quarter compared to the first, with net revenue increasing 58% to $10.2 million. However, the stock is still down. While some analysts believe that Cronos is taking a more fiscally responsible approaching to its growth strategy, investors are a bit more impatient, wanting to see some major moves from this company with all this cash.
The stock is currently down 3% year to date after seeing quite the rise in early 2019.
Out of these two CBD buys, I would definitely consider Charlotteâ€™s Web over Cronos at this point. I tend to stick with investors on this one. Cronos still has a way to go to even try and compete with Charlotteâ€™s Web and hasnâ€™t made any big moves to excite me into buying it. Meanwhile, Charlotteâ€™s Web has a solid place in the CBD market and should continue to see growth for years to come. The fact itâ€™s already profitable is also an incredibly positive sign.
The first wave of cannabis legalization minted millionaires out of everyday investors, and it might be about to happen again.
Because when edibles are legalized in Canada on October 17th, experts project a new $2.7 BILLION market will be born.
Our last legalization stock pick is already up 1,211%, and now we’re recommending one tiny small-cap stock before Cannabis 2.0.
This could be our next +1,000% winner in the cannabis space.
Hurry, the second wave of cannabis legalization is about to hit and this stock could skyrocket.
Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool owns shares of Charlotte’s Web Holdings.